Latest Breaking News On - Valentin handschin - Page 4 : comparemela.com

Newron announces H1 2023 results and provides R&D update

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Half Year ResultsNewron announces H1 2023 results and provides R&D update 04.08.2023 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Newron announces H1 2023 results and provides R&D updateMilan, Italy, August 4, 202.

Comunidad autonoma de catalunaUnited kingdomSouth koreaCity ofUnited statesKyongsang buktoUnited arab emiratesPaul saganJ donald donDeutsches eigenkapitalforumAnne hennecke caroline bergmannRoberto galliStefan weberValentin handschinLaura faravelliBusiness development

EQS-News: Newron announces H1 2023 results and provides R&D update

EQS-News: Newron Pharmaceuticals S.p.A. / Key word(s): Half Year Results Newron announces H1 2023 results and prov.

United statesUnited arab emiratesUnited kingdomSouth koreaComunidad autonoma de catalunaCity ofKyongsang buktoDeutsches eigenkapitalforumStefan weberLaura faravelliValentin handschinPaul saganRoberto galliJ donald donAnne hennecke caroline bergmannEuropean college of neuropsychopharmacology

Newron Pharmaceuticals S p A : Newron Announces H1 2023 Results and Provides R&D Update

Newron Pharmaceuticals S p A : Newron Announces H1 2023 Results and Provides R&D Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaUnited kingdomSouth koreaUnited arab emiratesCity ofKyongsang buktoUnited statesValentin handschinJ donald donLaura faravelliPaul saganRoberto galliDeutsches eigenkapitalforumStefan weberAnne hennecke caroline bergmannEuropean college of neuropsychopharmacology

pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Bernhard scholzOliverr baumannValentin handschinStock exchangeBoard of directors xlife sciencesManagement teamXlife sciencesXlife sciences ag keySwiss exchangeOrdinary annual general meetingChairman bernhard scholzHalf yearYear report

Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

EQS-News: Newron Pharmaceuticals S.p.A. / Key word: Conference/Study results Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and. | May 15, 2023

United statesSouth koreaKyongsang buktoSri lankaUnited kingdomUnited arab emiratesPaul saganValentin handschinAnne hennecke caroline bergmannStefan weberRavi anandMc servicesNewron pharmaceuticalsSchizophrenia international research societySwiss exchangeWorld congress